Bispecific Antibodies in Hematological Malignancies: A Scoping Review

SIMPLE SUMMARY: Bispecific T-cell engagers (BiTEs) and bispecific antibodies (BiAbs) have emerged as novel therapeutic modalities in the treatment of advanced hematological malignancies. BiTEs and BiAbs redirect T cells to attack tumors and facilitate T-cell-mediated cell death. Blinatumomab was the...

Descripción completa

Detalles Bibliográficos
Autores principales: Omer, Mohamed H., Shafqat, Areez, Ahmad, Omar, Alkattan, Khaled, Yaqinuddin, Ahmed, Damlaj, Moussab
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526328/
https://www.ncbi.nlm.nih.gov/pubmed/37760519
http://dx.doi.org/10.3390/cancers15184550

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526328/
https://www.ncbi.nlm.nih.gov/pubmed/37760519
http://dx.doi.org/10.3390/cancers15184550

Ejemplares similares